ADVERTISEMENT

Business Strategies

Rapidly Changing Market Demands Quick Study From Consumer Health, Personal Care Marketers

“It is shifting so quickly. It's shifting underneath our feet,” says NielsenIQ wellness VP Sherry Frey. Even comparing the past year to the preceding eight, “it's just accelerating quicker and quicker, and one of the biggest areas is online.”

Q1 IPOs Rise From Q4, But Unstable Markets Could Slow New Offerings

There were six biopharma initial public offerings on Western stock exchanges, including five in the US, during the first quarter, but plunging stock values could halt further IPOs.

What Is Fuelling Cell And Gene Therapies In India?

Bharat Biotech is the latest entrant in India’s cell and gene therapy space, joining majors like Intas Pharma, Sun Pharma, Cipla and Dr. Reddy’s. An indigenously developed CAR-T cell therapy launched last year, what is driving growing interest and success in cell and gene therapies?

US Consumer Health Industry Buckles Up For Another Ride As Trump Swings Tariff Tool Again

Manufacturers, marketers and other businesses in the industry may be thinking, “Well, this is different” because the president ordered tariffs on a list of countries rather than on his sole first-term target of China.

Pharma Exhales, Dodges Financial Blow With Tariff Exemption

Industry lobbing for pharmaceuticals to be exempt from President Trump’s sweeping US tariffs appears to have paid off.

Finance Watch: As Stocks Tumble, Offerings Slow, Financial Alternatives Rise

Public Company Edition: Stock valuations are falling due to political, economic and regulatory uncertainty, resulting in fewer large public offerings, more alternative financings and cost cuts. Carisma, Tenaya, BioAtla, Arbutus, Nkarta, Alector and Adaptimmune announced layoffs.

First At-Home Test For Multiple STIs Gets FDA Clearance

The Visby Medical Women’s Sexual Health Test is the first over-the-counter test cleared by the US Food and Drug Administration to detect chlamydia, gonorrhea and trichomoniasis. It delivers results in about 30 minutes.

AIRNA To Take RNA Editing Into The Clinic With $155m Series B Round

CEO Kris Elverum told Scrip about the start-up’s platform for editing RNA to correct genetic variants that cause harm and to reproduce healthy variants as a means of treating disease.

On The Move: New CMO For Oura Health, COO For AbundaBox

Leann Sims joins AbundaBox as COO; Oura Ring firm appoints CMO.

US Consumer Health Executive News: Ibis, Radicle Science, AbundaBox, Oura, Vegamour, Vertosa

Ibis Reproductive Health adds Desiree Williams to lead MORE Study; Radicle Science adds Rob Sinnott as senior strategic advisor; Leann Sims joins AbundaBox as COO; former Cannabis Beverage Association president moves to Vertosa; Vegamour expands executive staff with CMO; and Oura Ring firm appoints CMO.